References
- Center for Health Statistics and Information, National Health and Family Planning Commission. China Health Statistics Digest 2012. Beijing: NHFPC, 2012. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2012/index2012.html. Accessed April 30, 2016
- Wagner AK, Quick JD, Ross-Degnan D. Quality use of medicines within universal health coverage: challenges and opportunities. BMC Health Serv Res 2014;14:357
- National Audit Office of China. National Social Security Fund Audit Report- New Rural Social Security, Urban Resident Social Security and Urban & Rural Resident Social Security Audit Report. No. 34 Announcement of 2012. Beijing: National Audit Office of China, 2012
- Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, et al. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health 2012;15:664
- Zeng W. A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China. BMC Health Serv Res 2013;13:390-8.http://www.biomedcentral.com/1472-6963/13/390.
- IMS Health Institute China. Chinese Hospital Medicines Statistic Report 2014. Beijing: IMS, 2015
- IMS Health Institute China. A panoramic review of Chinese Pharmaceutical Market 2014. Beijing: IMS, 2015
- IMS Health Institute China. Opportunities in the Challenges-Review and the way forward of Chinese Hospital Pharmaceutical market 2014. IMS View Points. Issue 22. Beijing: IMS, 2015
- Xu Y, Wang L, He J, et al. 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-59
- MSH (Management Sciences for Health). International Drug Price Indicator Guide, 2012 edn. (Updated annually.). Medford, MA: MSH, 2013
- MSH (Management Sciences for Health). International Drug Price Indicator Guide, 2013 edn. (Updated annually.). Medford, MA: MSH, 2014.
- WHO, HAI. Measuring medicine prices, availability, affordability and price components, 2nd edn. WHO/PSM/PAR/2008.3. Switzerland: World Health Organization and Health Action International, 2008
- State Administration of Foreign Exchange. Middle exchange rate. Beijing: SAFE, 2016. http://www.safe.gov.cn/wps/portal/sy/tjsj_hlzjj_inquire. Accessed April 30, 2016
- AREPPIM: Information, pure and simple. Current to Real Dollars Converter (using GDP deflator). Switzerland: areppim AG, 2016. http://stats.areppim.com/calc/calc_usdlrxdeflator.php. Accessed April 30, 2016
- The Ministry of Human Resource and Social Security, P.R.China. Statistical Bulletin of Human Resources and Social Security Development. Beijing: MOHRSS, 2012. http://www.mohrss.gov.cn/SYrlzyhshbzb/zwgk/szrs/ndtjsj/tjgb/201306/t20130603_104411.htm. Accessed April 30, 2016
- The Ministry of Human Resource and Social Security, P.R.China. Statistical Bulletin of Human Resources and Social Security Development. Beijing: MOHRSS, 2013. http://www.mohrss.gov.cn/SYrlzyhshbzb/zwgk/szrs/ndtjsj/tjgb/201405/t20140529_131147.htm. Accessed April 30, 2016
- The Ministry of Human Resource and Social Security, P.R.China. Human Resource and Social Security Annual Data. Beijing: MOHRSS, 2014. http://www.mohrss.gov.cn/SYrlzyhshbzb/zwgk/szrs/dtyjsu/201502/t20150226_152554.htm. Accessed April 30, 2016
- The National Health and Family Planning Commission, P.R.China. Statistical Bulletin of Health and Family Planning Development. Beijing: MHFPC, 2012. http://www.nhfpc.gov.cn/mohwsbwstjxxzx/s7967/201306/fe0b764da4f74b858eb55264572eab92.shtml. Accessed April 30, 2016
- The National Health and Family Planning Commission, P.R.China. Statistical Bulletin of Health and Family Planning Development. Beijing: NHFPC, 2013. http://www.nhfpc.gov.cn/guihuaxxs/s10742/201405/886f82dafa344c3097f1d16581a1bea2.shtml. Accessed April 30, 2016
- MSH (Management Sciences for Health). International Drug Price Indicator Guide, 2012 edn. (Updated annually.). Medford, MA: MSH, 2013
- The World Health Organization. World Health Statistics 2015. WHO: Geneva, 2015
- IMS Health Institute China. Global Outlook for Medicines through 2018. Beijing: IMS, 2015
- Sun J. Developing comprehensive and integrated health system reform policies to improve use of medicines. [Groningen]: Rijksuniversiteit Groningen, 2015. p 189.
- Sun J. International experiences of promoting generics uptake and its implications to China. J Evidence-based Med 2013;6:74-80
- State Food and Drug Administration. The announcement of re-evaluating generics. Document No. 34 of 2013. Beijing: SFDA, 2013. http://www.sda.gov.cn/WS01/CL0844/78516.html. Accessed April 30, 2016
- The State Council. The announcement of the 12th National Five-year Plan for Drug Safety. Document No. 5 of 2012. Beijing: SC, 2012. http://www.gov.cn/zwgk/2012–02/13/content_2065197.htm. Accessed April 30, 2016
- Wang L, Lin M, Yang M, et al. Quality gaps between imported and local medicines and risk control. China Pharmaceut Affairs 2012;26:224-8
- Vogler S. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries-an overview. Generics Biosimilars Initiative J 2012;1:44-51
- Kaplan WA, Ritz LS, Vitello M, et al. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010. Health Policy 2012;106:211
- China Food and Drug Administration. Announcement of the Registration Fees. No. 53 Document of 2015. Beijing: CFDA, 2015. http://www.sda.gov.cn/WS01/CL0144/. Accessed April 30, 2016
- China National Health Development Research Center. National Health Accounts 2013. CNHDRC: Beijing, 2014
- OECD Health Data: Health expenditure and financing: OECD Health Statistics (database). Pharmaceutical expenditure per capita. At current prices and PPPs. Paris: OECD Publishing, 2012. http://www.oecd-ilibrary.org/social-issues-migration-health/pharmaceutical-expenditure-per-capita-2012-1_pharmexpcap-table-2012-1-en. Accessed November 26, 2015